I disagree that "this hold means nothing to ADXS", or to the market.
IMO, the market was tuned in to what Petit said about the hold. The below is Petit's last comment on the hold during the last conference call. Bolding is mine.
IMO, until the hold is removed and ADXS confirms that nothing needs "more broad attention", buying pressure will be subdued.
The fact that the hold was only issued for the one trial is certainly good news, yet Petit's comment on the potential for broader impacts is hindering buying pressure, IMO.
-----------------------------
"And I think that it’s too early to speak about whether or not there is any potential read-through we are still trying to gather all the medical facts of the case to try to discern what happens here and whether or not it was just a patient-specific issue or was something that needs a more broad attention."
News 
Market Data 
Discover 
AI
